First Time Loading...

Compugen Ltd
NASDAQ:CGEN

Watchlist Manager
Compugen Ltd Logo
Compugen Ltd
NASDAQ:CGEN
Watchlist
Price: 1.88 USD
Updated: Apr 19, 2024

Operating Margin
Compugen Ltd

-38.8%
Current
-713%
Average
4.1%
Industry
Negative for the last year
-38.8%
Negative average
-713%
Better than average
Worse than industry value

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-38.8%
=
Operating Profit
-13m
/
Revenue
33.5m

Operating Margin Across Competitors

Operating Margin Comparison
Compugen Ltd Competitors

Country Company Market Cap Operating
Margin
IL
Compugen Ltd
NASDAQ:CGEN
167.8m USD
-39%
US
Thermo Fisher Scientific Inc
NYSE:TMO
210.2B USD
17%
US
Danaher Corp
NYSE:DHR
173.7B USD
22%
US
IQVIA Holdings Inc
NYSE:IQV
41.3B USD
14%
KR
Samsung Biologics Co Ltd
KRX:207940
55.6T KRW
30%
CH
Lonza Group AG
SIX:LONN
36.2B CHF
20%
US
Agilent Technologies Inc
NYSE:A
39B USD
19%
US
West Pharmaceutical Services Inc
NYSE:WST
27.7B USD
24%
US
Mettler-Toledo International Inc
NYSE:MTD
25.7B USD
29%
IE
ICON PLC
NASDAQ:ICLR
23.7B USD
13%
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.5B EUR
17%
Compugen Ltd
NASDAQ:CGEN
Country IL
Market Cap 167.8m USD
Operating Margin
-39%
Thermo Fisher Scientific Inc
NYSE:TMO
Country US
Market Cap 210.2B USD
Operating Margin
17%
Danaher Corp
NYSE:DHR
Country US
Market Cap 173.7B USD
Operating Margin
22%
IQVIA Holdings Inc
NYSE:IQV
Country US
Market Cap 41.3B USD
Operating Margin
14%
Samsung Biologics Co Ltd
KRX:207940
Country KR
Market Cap 55.6T KRW
Operating Margin
30%
Lonza Group AG
SIX:LONN
Country CH
Market Cap 36.2B CHF
Operating Margin
20%
Agilent Technologies Inc
NYSE:A
Country US
Market Cap 39B USD
Operating Margin
19%
West Pharmaceutical Services Inc
NYSE:WST
Country US
Market Cap 27.7B USD
Operating Margin
24%
Mettler-Toledo International Inc
NYSE:MTD
Country US
Market Cap 25.7B USD
Operating Margin
29%
ICON PLC
NASDAQ:ICLR
Country IE
Market Cap 23.7B USD
Operating Margin
13%
Sartorius Stedim Biotech SA
PAR:DIM
Country FR
Market Cap 18.5B EUR
Operating Margin
17%

Profitability Report

View the profitability report to see the full profitability analysis for Compugen Ltd.

Full Profitability Report

See Also

Summary
CGEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
CGEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CGEN stock valuation using valuation multiples.
Wall Street Estimates
CGEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CGEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-38.8%
=
Operating Profit
-13m
/
Revenue
33.5m
What is the Operating Margin of Compugen Ltd?

Based on Compugen Ltd's most recent financial statements, the company has Operating Margin of -38.8%.

ALPHA SPREAD
Join more than 129,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.